Editas Medicine Vs. Biogen Industry Stock Comparison

Sell

37

EDIT
Editas Medicine

Last Price:

3.77

Seasonality Move:

10.81%

Sell

37

BIIB
Biogen

Last Price:

199.29

Seasonality Move:

9.16%

Sell

37

Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

The current Editas Medicine [EDIT] share price is $3.77. The Score for EDIT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

37

Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

The current Biogen [BIIB] share price is $199.36. The Score for BIIB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

The Editas Medicine share price today is $3.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

BIIB Stock Price Chart

What is Biogen's stock price today?

The Biogen share price today is $199.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing slight buying pressure.

EDIT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.11	Sell
Relative Strength Index (14 RSI):	44.16	Sell
Chaikin Money Flow:	-268969	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.62 - 3.96)	Sell
Bollinger Bands (100):	(4.08 - 5.62)	Sell

BIIB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.43	Sell
Relative Strength Index (14 RSI):	43.7	Sell
Chaikin Money Flow:	1538781	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(198.98 - 205.06)	Sell
Bollinger Bands (100):	(204.63 - 228.99)	Sell

EDIT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.84	Sell
20-day SMA:	3.74	Buy
50-day SMA:	4.38	Sell
200-day SMA:	6.55	Sell
8-day EMA:	3.82	Sell
20-day EMA:	3.85	Sell
50-day EMA:	4.24	Sell
200-day EMA:	6.02	Sell

BIIB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	198.55	Buy
20-day SMA:	201.38	Sell
50-day SMA:	207.79	Sell
200-day SMA:	223.53	Sell
8-day EMA:	199.4	Sell
20-day EMA:	201.12	Sell
50-day EMA:	206.76	Sell
200-day EMA:	223.03	Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.

Biogen Earnings Growth & BIIB Earnings Dates

Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.03 per share, an increase this year of $1.16 per share, and an increase next year of $0.78 per share.

Editas Medicine Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biogen Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):